Cargando…
Synthetic and External Controls in Clinical Trials – A Primer for Researchers
There has been a rapid expansion in the use of non-randomized evidence in the regulatory approval of treatments globally. An emerging set of methodologies have been utilized to provide greater insight into external control data used for these purposes, collectively known as synthetic control methods...
Autores principales: | Thorlund, Kristian, Dron, Louis, Park, Jay J H, Mills, Edward J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218288/ https://www.ncbi.nlm.nih.gov/pubmed/32440224 http://dx.doi.org/10.2147/CLEP.S242097 |
Ejemplares similares
-
Key design considerations for adaptive clinical trials: a primer for clinicians
por: Thorlund, Kristian, et al.
Publicado: (2018) -
A real-time dashboard of clinical trials for COVID-19
por: Thorlund, Kristian, et al.
Publicado: (2020) -
Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials
por: Park, Jay JH., et al.
Publicado: (2019) -
Minimizing control group allocation in randomized trials using dynamic borrowing of external control data – An application to second line therapy for non-small cell lung cancer
por: Dron, Louis, et al.
Publicado: (2019) -
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
por: Park, Jay J. H, et al.
Publicado: (2019)